Filing Details
- Accession Number:
- 0001415889-25-020458
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-29 16:52:29
- Reporting Period:
- 2025-07-25
- Filing Date:
- 2025-07-29
- Accepted Time:
- 2025-07-29 16:52:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534133 | Calcimedica Inc. | CALC | Pharmaceutical Preparations (2834) | 452120079 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1969388 | A. Kenneth Stauderman | Calcimedica, Inc. 505 Coast S. Blvd. #307 La Jolla CA 92037 | Chief Scientific Officer | No | No | No | No |
Transaction Summary
Purchased: | 1,000 shares | Avg. Price: $3.96 | Total Value: $3,960.00 |
Sold: | 1,000 shares | Avg. Price: $3.65 | Total Value: $3,650.00 |
Number of Shares After Transactions: | 12,944 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-07-25 | 1,000 | $3.65 | 0 | No | 4 | S | Indirect | By Spouse |
Common Stock | Acquisiton | 2025-07-28 | 1,000 | $3.96 | 12,944 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Spouse |
No | 4 | P | Direct |
Footnotes
- The sale of the common stock of CalciMedica, Inc. (the "Issuer") by the spouse of the reporting person reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person's spouse at a price of $1.85 per share on July 1, 2025. The reporting person has agreed to pay to the Issuer upon settlement of the sale, $1,799.83, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.